Need help finding what you are looking for?
Contact Us
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2112298
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2112298
Anatomic Pathology Market by Product [Consumables (Histopathology, Cytopathology), Instruments, Software], Process, Disease (Breast, GI, Prostate), End User (Hospitals, Research Labs), Services, Model (In House, Outsourced) - Global Forecast to 2031
PUBLISHED:
PAGES: 458 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The anatomic pathology market is projected to grow from USD 8.9 billion in 2026 to USD 14.5 billion by 2031, at a CAGR of 10.2%. The increasing global prevalence of cancer and other chronic diseases is driving demand for histopathology, cytopathology, and biomarker-based diagnostic testing. As healthcare systems increasingly adopt personalized medicine approaches, the need for accurate tissue characterization and biomarker assessment is expanding across a wide range of cancer types.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2026-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | Product Market (Type, Process, Disease, End User, and Region) and Service Market (Type, Model, and Disease) |
| Regions covered | North America, Asia Pacific, Europe, the Middle East & Africa, and Latin America |
Furthermore, advancements in digital pathology, artificial intelligence, laboratory automation, and multiplex tissue analysis technologies are improving diagnostic efficiency, workflow standardization, and clinical decision-making. These innovations are enabling healthcare providers to deliver more accurate and timely diagnoses, thereby supporting the growth of the anatomic pathology market.
"The breast cancer segment is expected to account for the largest share of the anatomic pathology market, by disease type."
Based on disease type, the anatomic pathology market is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small-cell lung cancer (NSCLC), and other diseases. The breast cancer segment accounts for the largest market share due to the high global incidence of the disease and the extensive use of anatomic pathology techniques for disease diagnosis, classification, grading, and treatment planning. Pathology laboratories routinely utilize histopathology, immunohistochemistry (IHC), in situ hybridization (ISH), and biomarker assessment to support comprehensive evaluation of breast tissue specimens. Additionally, the increasing emphasis on early cancer detection, growing breast cancer screening initiatives, and rising demand for accurate pathological characterization continue to drive the adoption of anatomic pathology solutions, making breast cancer the largest disease segment within the market.
"The hospitals segment is expected to account for the largest share of the anatomic pathology market."
The global anatomic pathology market can be segmented by end user into hospitals, research laboratories, pharmaceutical companies, contract research organizations (CROs), and other end users. Among these, the hospitals segment accounted for the largest market share. Hospitals remain the primary setting for anatomic pathology testing due to the high volume of cancer diagnoses, surgical procedures, and tissue-based examinations performed within integrated healthcare systems. Furthermore, the increasing availability of advanced pathology infrastructure, growing adoption of laboratory automation and digital pathology technologies, and rising demand for timely and accurate diagnostic services are expected to support the continued utilization of anatomic pathology solutions across hospital-based laboratories worldwide.
"The Asia Pacific is the fastest-growing market for anatomic pathology from 2026 to 2031."
The global anatomic pathology market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is projected to grow at the highest regional CAGR from 2026 to 2031. The region is witnessing a rapid increase in cancer incidence, creating significant demand for histopathology, cytopathology, and biomarker-based diagnostic services. China is expanding pathology laboratory capacity through healthcare infrastructure modernization initiatives and increasing investments in cancer diagnostics. India's growing network of tertiary-care hospitals, cancer centers, and private diagnostic laboratories is accelerating the adoption of advanced pathology technologies and laboratory automation. Meanwhile, Japan's aging population, high cancer screening rates, and increasing adoption of digital pathology solutions continue to support the expansion of the anatomic pathology market across the region.
The break-up of the profiles of primary participants in the anatomic pathology market:
- By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
- By Designation: C-level Executives (27%), Directors (18%), and Others (55%)
- By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%)
F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), PHC Holdings Corporation (Japan), Hologic, Inc. (US), Agilent Technologies, Inc. (US), Becton, Dickinson and Company (US), Koninklijke Philips N.V. (Netherlands), Merck KGaA (Germany), Bio SB (US), and Sakura Finetek Japan Co., Ltd. (Japan) are some of the key players in the anatomic pathology market.
Research Coverage:
This research report categorizes the anatomic pathology market into the product market by type (consumables, instruments, software, and storage systems), product market by process (preanalytics/sample preparation, advanced staining/IHC, primary & special staining, and digital pathology), product market by disease (breast cancer, gastric cancer, lymphoma, prostate cancer, non-small-cell lung cancer, and other diseases), product market by end user (hospitals, research laboratories, pharmaceutical companies, contract research organizations, and other end users), service market by type (histopathology services and cytopathology services), service market by model (in-house and outsourced), service market by disease (breast cancer, gastric cancer, lymphoma, prostate cancer, non-small-cell lung cancer, and other diseases), and by region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).
The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the anatomic pathology market. A detailed analysis of the key industry players has been done to provide insights into their business overview; solutions; key strategies such as acquisitions, agreements, and product & service launches; and recent developments associated with the anatomic pathology market. Competitive analysis of upcoming startups in the anatomic pathology market ecosystem is covered in this report.
Reasons to buy this report:
The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall anatomic pathology market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (high incidence of cancer and other target diseases, growing demand for digital pathology, availability of reimbursement, and growing focus on personalized medicine), restraints (high cost of instruments and consumables), opportunities (expansion potential across emerging economies and increasing number of clinical trials for cancer therapeutics), and challenges (availability of refurbished products, stringent regulatory requirements, and shortage of skilled professionals) influencing the growth of the anatomic pathology market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the anatomic pathology market.
- Market Development: Comprehensive information about lucrative markets-the report analyzes the anatomic pathology market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the anatomic pathology market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), PHC Holdings Corporation (Japan), Hologic, Inc. (US), Agilent Technologies, Inc. (US).
Product Code: MD 5104
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.4 CURRENCY CONSIDERED
- 1.5 STAKEHOLDERS
- 1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
- 2.2 KEY MARKET PARTICIPANTS: INSIGHTS & STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
- 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
- 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 ANATOMIC PATHOLOGY PRODUCT MARKET OVERVIEW
- 3.2 ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2026 VS. 2031
- 3.3 ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2026 VS. 2031
- 3.4 ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2026 VS. 2031
- 3.5 ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2026 VS. 2031
- 3.6 ANATOMIC PATHOLOGY PRODUCT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 High incidence of cancer and other target diseases
- 4.2.1.2 Growing demand for digital pathology
- 4.2.1.3 Availability of reimbursement
- 4.2.1.4 Growing focus on personalized medicine
- 4.2.2 RESTRAINTS
- 4.2.2.1 High cost of instruments and consumables
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Expansion potential across emerging economies
- 4.2.3.2 Increasing number of clinical trials for cancer therapeutics
- 4.2.4 CHALLENGES
- 4.2.4.1 Availability of refurbished products
- 4.2.4.2 Stringent regulatory requirements
- 4.2.4.3 Shortage of skilled professionals
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS & WHITE SPACES
- 4.3.1 UNMET NEEDS IN ANATOMIC PATHOLOGY MARKET
- 4.3.2 WHITE SPACE OPPORTUNITIES
- 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
- 4.4.1 INTERCONNECTED MARKETS
- 4.4.2 CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
- 4.5.1 KEY MOVES & STRATEGIC FOCUS
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 BARGAINING POWER OF SUPPLIERS
- 5.1.2 BARGAINING POWER OF BUYERS
- 5.1.3 THREAT OF NEW ENTRANTS
- 5.1.4 THREAT OF SUBSTITUTES
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.2 MACROECONOMIC INDICATORS
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS & FORECAST
- 5.3 SUPPLY CHAIN ANALYSIS
- 5.4 VALUE CHAIN ANALYSIS
- 5.5 ECOSYSTEM ANALYSIS
- 5.5.1 ANATOMIC PATHOLOGY MARKET: ROLE OF COMPANIES IN ECOSYSTEM
- 5.6 PRICING ANALYSIS
- 5.6.1 AVERAGE SELLING PRICE OF ANATOMIC PATHOLOGY PRODUCTS, BY KEY PLAYER, 2024-2026
- 5.6.2 AVERAGE SELLING PRICE OF ANATOMIC PATHOLOGY PRODUCTS, BY REGION, 2024-2026
- 5.7 TRADE ANALYSIS
- 5.7.1 IMPORT SCENARIO (HS CODE 3822)
- 5.7.2 EXPORT SCENARIO (HS CODE 3822)
- 5.8 KEY CONFERENCES & EVENTS, 2026-2027
- 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.10 INVESTMENT & FUNDING SCENARIO
- 5.11 CASE STUDY ANALYSIS
- 5.11.1 CASE STUDY 1: OPTIMIZING AUTOMATED TISSUE PROCESSING EFFICIENCY TO REDUCE COST
- 5.11.2 CASE STUDY 2: OPERATIONAL EFFICIENCY IMPROVEMENTS THROUGH MILESTONE MEDICAL TISSUE PROCESSOR IMPLEMENTATION
- 5.11.3 CASE STUDY 3: WORKFLOW OPTIMIZATION THROUGH EXCELSIOR AS TISSUE PROCESSOR
- 5.12 IMPACT OF 2025 US TARIFFS ON ANATOMIC PATHOLOGY MARKET
- 5.12.1 INTRODUCTION
- 5.12.2 KEY TARIFF RATES
- 5.12.3 PRICE IMPACT ANALYSIS
- 5.12.4 IMPACT ON REGION
- 5.12.4.1 North America
- 5.12.4.2 Europe
- 5.12.4.3 Asia Pacific
- 5.12.5 IMPACT ON END-USE INDUSTRIES
- 5.12.5.1 Hospitals
- 5.12.5.2 Research laboratories
- 5.12.5.3 Pharmaceutical companies
- 5.12.5.4 Contract research organizations (CROs)
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
- 6.1 KEY EMERGING TECHNOLOGIES
- 6.1.1 HISTOPATHOLOGY
- 6.1.2 CYTOPATHOLOGY
- 6.1.3 DIGITAL PATHOLOGY
- 6.2 COMPLEMENTARY TECHNOLOGIES
- 6.2.1 SPECIAL STAINING
- 6.3 ADJACENT TECHNOLOGIES
- 6.3.1 MASS SPECTROMETRY IMAGING (MSI)
- 6.4 TECHNOLOGY/PRODUCT ROADMAP
- 6.4.1 SHORT-TERM (2025-2027) | OPTIMIZATION & STANDARDIZATION OF CORE REAGENTS
- 6.4.1.1 Core technology development
- 6.4.1.2 Product innovations
- 6.4.1.3 Market adoption
- 6.4.2 MID-TERM (2027-2030) | EXPANDED CAPABILITIES & SUSTAINABILITY
- 6.4.2.1 Advanced technology development
- 6.4.2.2 Product innovations
- 6.4.2.3 Market adoption
- 6.4.3 LONG-TERM (2030-2035+) | HIGH-PERFORMANCE & ECO-EFFICIENT PRODUCTS
- 6.4.3.1 High-performance & integrated workflows
- 6.4.3.2 Product innovations
- 6.4.3.3 Market adoption
- 6.4.1 SHORT-TERM (2025-2027) | OPTIMIZATION & STANDARDIZATION OF CORE REAGENTS
- 6.5 PATENT ANALYSIS
- 6.5.1 LIST OF MAJOR PATENTS
- 6.5.1.1 List of key patents
- 6.5.1 LIST OF MAJOR PATENTS
- 6.6 FUTURE APPLICATIONS
- 6.7 IMPACT OF AI/GENERATIVE AI ON ANATOMIC PATHOLOGY MARKET
- 6.7.1 INTRODUCTION
- 6.7.2 TOP USE CASES & MARKET POTENTIAL
- 6.7.3 KEY COMPANIES IMPLEMENTING AI
- 6.7.4 FUTURE OF AI
7 SUSTAINABILITY & REGULATORY LANDSCAPE
- 7.1 REGIONAL REGULATIONS & COMPLIANCE
- 7.1.1 REGULATORY ANALYSIS
- 7.1.1.1 North America
- 7.1.1.1.1 US
- 7.1.1.1.2 Canada
- 7.1.1.2 Europe
- 7.1.1.2.1 Germany
- 7.1.1.2.2 UK
- 7.1.1.2.3 France
- 7.1.1.3 Asia Pacific
- 7.1.1.3.1 China
- 7.1.1.3.2 Japan
- 7.1.1.3.3 India
- 7.1.1.4 Latin America
- 7.1.1.5 Middle East
- 7.1.1.5.1 Africa
- 7.1.1.1 North America
- 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.1 REGULATORY ANALYSIS
- 7.2 SUSTAINABILITY INITIATIVES
- 7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN ANATOMIC PATHOLOGY MARKET
- 7.2.1.1 Eco-friendly initiatives
- 7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN ANATOMIC PATHOLOGY MARKET
- 7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 8.1 DECISION-MAKING PROCESS
- 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 BUYING CRITERIA
- 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
- 8.5 MARKET PROFITABILITY
- 8.5.1 REVENUE POTENTIAL
- 8.5.2 COST DYNAMICS
- 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9 ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE
- 9.1 INTRODUCTION
- 9.2 CONSUMABLES
- 9.2.1 HISTOPATHOLOGY CONSUMABLES
- 9.2.1.1 Histopathology antibodies
- 9.2.1.1.1 Primary histopathology antibodies
- 9.2.1.1.1.1 Increasing adoption of precision medicine to drive market growth
- 9.2.1.1.2 Secondary histopathology antibodies
- 9.2.1.1.2.1 Growing focus on highly specific polymers to drive demand for histopathology secondary antibodies
- 9.2.1.1.1 Primary histopathology antibodies
- 9.2.1.2 Histopathology kits & reagents
- 9.2.1.2.1 Histopathology stains & solvents
- 9.2.1.2.1.1 Increasing adoption of advanced tissue staining techniques to drive growth of histopathology stains & solvents
- 9.2.1.2.2 Histopathology fixatives
- 9.2.1.2.2.1 Growing emphasis on tissue preservation and biomarker integrity to drive demand for histopathology fixation reagents
- 9.2.1.2.3 Other histopathology kits & reagents
- 9.2.1.2.1 Histopathology stains & solvents
- 9.2.1.3 Histopathology probes
- 9.2.1.3.1 Growing adoption of tissue-based pathology and precision diagnostics to drive demand for histopathology probes
- 9.2.1.4 Other histopathology consumables
- 9.2.1.1 Histopathology antibodies
- 9.2.2 CYTOPATHOLOGY CONSUMABLES
- 9.2.2.1 Cytopathology antibodies
- 9.2.2.1.1 Primary cytopathology antibodies
- 9.2.2.1.1.1 Advancements in biomarker research using cell analysis to support market growth
- 9.2.2.1.2 Secondary cytopathology antibodies
- 9.2.2.1.2.1 Expanding use of cytopathology for cancer screening to accelerate demand
- 9.2.2.1.1 Primary cytopathology antibodies
- 9.2.2.2 Cytopathology kits & reagents
- 9.2.2.2.1 Cytopathology stains & solvents
- 9.2.2.2.1.1 Growing demand for cytology-based screening and cellular diagnostics to fuel cytopathology stains & solvents market
- 9.2.2.2.2 Cytopathology fixatives
- 9.2.2.2.2.1 Rising adoption of cytology-based screening and liquid-based cytology to support growth of cytopathology fixation reagents
- 9.2.2.2.3 Other cytopathology kits & reagents
- 9.2.2.2.1 Cytopathology stains & solvents
- 9.2.2.3 Cytopathology probes
- 9.2.2.3.1 Increasing research to aid market growth
- 9.2.2.4 Other cytopathology consumables
- 9.2.2.1 Cytopathology antibodies
- 9.2.1 HISTOPATHOLOGY CONSUMABLES
- 9.3 INSTRUMENTS
- 9.3.1 SLIDE STAINING SYSTEMS
- 9.3.1.1 Availability of automated systems to drive market growth
- 9.3.2 TISSUE PROCESSING SYSTEMS
- 9.3.2.1 Rising adoption of automation to drive market growth
- 9.3.3 CELL PROCESSORS
- 9.3.3.1 Technological advancements in cytopathology testing to support growth of this market
- 9.3.4 MICROTOMES
- 9.3.4.1 Increasing demand for accurate tissue sectioning to support growth
- 9.3.5 EMBEDDING SYSTEMS
- 9.3.5.1 Advancements in tissue preparation technologies to support expansion of embedding systems market
- 9.3.6 COVERSLIPPERS
- 9.3.6.1 Increasing focus on laboratory automation and workflow efficiency to drive growth of coverslippers market
- 9.3.7 DIGITAL PATHOLOGY SCANNERS
- 9.3.7.1 Growing adoption of digital imaging to propel market
- 9.3.8 OTHER INSTRUMENTS
- 9.3.1 SLIDE STAINING SYSTEMS
- 9.4 SOFTWARE
- 9.4.1 AI-INTEGRATED SOFTWARE
- 9.4.1.1 Growing adoption of artificial intelligence in pathology workflows to accelerate demand for AI-integrated software
- 9.4.2 NON-AI-INTEGRATED SOFTWARE
- 9.4.2.1 Increasing digitalization of pathology laboratories to drive demand for non-AI pathology software
- 9.4.1 AI-INTEGRATED SOFTWARE
- 9.5 STORAGE SYSTEMS
- 9.5.1 GROWING ADOPTION OF DIGITAL PATHOLOGY AND INCREASING DATA VOLUMES TO DRIVE DEMAND FOR PATHOLOGY STORAGE SYSTEMS
10 ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS
- 10.1 INTRODUCTION
- 10.2 PREANALYTICS/SAMPLE PREPARATION
- 10.2.1 GROWING DEMAND FOR EFFICIENT SPECIMEN HANDLING AND LABORATORY AUTOMATION TO DRIVE GROWTH
- 10.3 ADVANCED STAINING/IHC
- 10.3.1 GROWING ADOPTION OF MULTIPLEX BIOMARKER ANALYSIS AND AUTOMATED STAINING WORKFLOWS TO SUPPORT MARKET GROWTH
- 10.4 PRIMARY & SPECIAL STAINING
- 10.4.1 GROWING DEMAND FOR SPECIALIZED TISSUE & CELLULAR CHARACTERIZATION TO DRIVE GROWTH
- 10.5 DIGITAL PATHOLOGY
- 10.5.1 GROWING ADOPTION OF WHOLE-SLIDE IMAGING AND AI-ENABLED WORKFLOWS TO DRIVE GROWTH OF DIGITAL PATHOLOGY
11 ANATOMIC PATHOLOGY MARKET, BY DISEASE
- 11.1 INTRODUCTION
- 11.2 BREAST CANCER
- 11.2.1 RISING UPTAKE OF HER2 TESTS FOR CANCER DIAGNOSIS TO FUEL MARKET
- 11.3 NON-SMALL-CELL LUNG CANCER
- 11.3.1 RISING CASES OF LUNG CANCER TO DRIVE ADOPTION
- 11.4 PROSTATE CANCER
- 11.4.1 GROWING RATE OF PROSTATE CANCER TO PROPEL MARKET
- 11.5 GASTRIC CANCER
- 11.5.1 RISING INCIDENCE OF GASTROINTESTINAL CANCER TO BOOST MARKET
- 11.6 LYMPHOMA
- 11.6.1 RISING INCIDENCE OF NON-HODGKIN'S LYMPHOMA IN ADULTS TO SUPPORT GROWTH
- 11.7 OTHER DISEASES
12 ANATOMIC PATHOLOGY MARKET VOLUME ANALYSIS, BY DISEASE (NUMBER OF TESTS)
13 ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER
- 13.1 INTRODUCTION
- 13.2 HOSPITALS
- 13.2.1 RISING HEALTHCARE INVESTMENT TO CONTRIBUTE TO GROWTH
- 13.3 RESEARCH LABORATORIES
- 13.3.1 RISING DEMAND FOR SPECIALTY TESTS TO DRIVE MARKET
- 13.4 PHARMACEUTICAL COMPANIES
- 13.4.1 INCREASING R&D ACTIVITIES FOR DISEASE DIAGNOSTICS TO DRIVE MARKET
- 13.5 CONTRACT RESEARCH ORGANIZATIONS
- 13.5.1 GROWING DEMAND FOR OUTSOURCING ANALYTICAL TESTING & CLINICAL TRIAL SERVICES TO BOOST MARKET
- 13.6 OTHER END USERS
14 ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE
- 14.1 INTRODUCTION
- 14.2 HISTOPATHOLOGY SERVICES
- 14.3 CYTOPATHOLOGY SERVICES
15 ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE
- 15.1 INTRODUCTION
- 15.2 IN-HOUSE
- 15.3 OUTSOURCED
16 ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE
- 16.1 INTRODUCTION
- 16.2 BREAST CANCER
- 16.2.1 NON-SMALL CELL LUNG CANCER
- 16.2.2 PROSTATE CANCER
- 16.2.3 GASTRIC CANCER
- 16.2.4 LYMPOMA
- 16.2.5 OTHER DISEASE TYPE
17 ANATOMIC PATHOLOGY MARKET, BY REGION
- 17.1 INTRODUCTION
- 17.2 NORTH AMERICA
- 17.2.1 US
- 17.2.1.1 High healthcare expenditure to drive market
- 17.2.2 CANADA
- 17.2.2.1 Rising prevalence of cancer to fuel market
- 17.2.1 US
- 17.3 EUROPE
- 17.3.1 GERMANY
- 17.3.1.1 Favorable government initiatives to boost market
- 17.3.2 UK
- 17.3.2.1 Rising investments in cancer research to drive market
- 17.3.3 FRANCE
- 17.3.3.1 Increasing demand for cancer diagnostics to propel market
- 17.3.4 ITALY
- 17.3.4.1 High incidence of cancer and geriatric population to support growth
- 17.3.5 SPAIN
- 17.3.5.1 Increased cancer cases to boost market
- 17.3.6 REST OF EUROPE
- 17.3.1 GERMANY
- 17.4 ASIA PACIFIC
- 17.4.1 CHINA
- 17.4.1.1 Increasing focus on healthcare infrastructure to boost market
- 17.4.2 JAPAN
- 17.4.2.1 Established healthcare system to fuel market
- 17.4.3 INDIA
- 17.4.3.1 Presence of large patient pool and rapidly growing healthcare sector to drive market
- 17.4.4 REST OF ASIA PACIFIC
- 17.4.1 CHINA
- 17.5 LATIN AMERICA
- 17.5.1 GROWING ONCOLOGY PATIENT POOL, COMBINED WITH EXPANDING PUBLIC AND PRIVATE INVESTMENTS IN CANCER CARE, TO BOOST GROWTH
- 17.6 MIDDLE EAST & AFRICA
- 17.6.1 GOVERNMENT INITIATIVES TO IMPROVE HEALTHCARE INFRASTRUCTURE TO AID ANATOMIC PATHOLOGY MARKET
18 COMPETITIVE LANDSCAPE
- 18.1 INTRODUCTION
- 18.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 18.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN ANATOMIC PATHOLOGY MARKET
- 18.3 REVENUE ANALYSIS, 2023-2025
- 18.4 MARKET SHARE ANALYSIS, 2025
- 18.4.1 GLOBAL MARKET SHARE ANALYSIS, 2025
- 18.4.2 US MARKET SHARE ANALYSIS, 2025
- 18.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 18.5.1 STARS
- 18.5.2 EMERGING LEADERS
- 18.5.3 PERVASIVE PLAYERS
- 18.5.4 PARTICIPANTS
- 18.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 18.5.5.1 Company footprint
- 18.5.5.2 Region footprint
- 18.5.5.3 Type footprint
- 18.5.5.4 Process footprint
- 18.5.5.5 End-user footprint
- 18.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 18.6.1 PROGRESSIVE COMPANIES
- 18.6.2 RESPONSIVE COMPANIES
- 18.6.3 DYNAMIC COMPANIES
- 18.6.4 STARTING BLOCKS
- 18.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 18.6.5.1 Detailed list of key startups/SMEs
- 18.6.5.2 Competitive benchmarking of startups/SMEs (1/2)
- 18.6.5.3 Competitive benchmarking of startups/SMEs (2/2)
- 18.7 COMPANY VALUATION & FINANCIAL METRICS
- 18.7.1 FINANCIAL METRICS
- 18.7.2 COMPANY VALUATION
- 18.8 BRAND/PRODUCT COMPARISON
- 18.9 COMPETITIVE SCENARIO
- 18.9.1 PRODUCT LAUNCHES & APPROVALS
- 18.9.2 DEALS
- 18.9.3 EXPANSIONS
19 COMPANY PROFILES
- 19.1 KEY PLAYERS
- 19.1.1 F. HOFFMANN-LA ROCHE LTD.
- 19.1.1.1 Business overview
- 19.1.1.2 Products offered
- 19.1.1.3 Recent developments
- 19.1.1.3.1 Product launches & approvals
- 19.1.1.3.2 Deals
- 19.1.1.4 MnM view
- 19.1.1.4.1 Key strengths
- 19.1.1.4.2 Strategic choices
- 19.1.1.4.3 Weaknesses & competitive threats
- 19.1.2 DANAHER CORPORATION
- 19.1.2.1 Business overview
- 19.1.2.2 Products offered
- 19.1.2.3 Recent developments
- 19.1.2.3.1 Product launches & approvals
- 19.1.2.3.2 Deals
- 19.1.2.4 MnM view
- 19.1.2.4.1 Key strengths
- 19.1.2.4.2 Strategic choices
- 19.1.2.4.3 Weaknesses & competitive threats
- 19.1.3 PHC HOLDINGS CORPORATION (EPREDIA)
- 19.1.3.1 Business overview
- 19.1.3.2 Products offered
- 19.1.3.3 Recent developments
- 19.1.3.3.1 Product launches & approvals
- 19.1.3.3.2 Deals
- 19.1.3.4 MnM view
- 19.1.3.4.1 Key strengths
- 19.1.3.4.2 Strategic choices
- 19.1.3.4.3 Weaknesses & competitive threats
- 19.1.4 AGILENT TECHNOLOGIES, INC.
- 19.1.4.1 Business overview
- 19.1.4.2 Products offered
- 19.1.4.3 Recent developments
- 19.1.4.3.1 Product launches
- 19.1.4.3.2 Deals
- 19.1.4.4 MnM view
- 19.1.4.4.1 Key strengths
- 19.1.4.4.2 Strategic choices
- 19.1.4.4.3 Weaknesses & competitive threats
- 19.1.5 HOLOGIC INC.
- 19.1.5.1 Business overview
- 19.1.5.2 Products offered
- 19.1.5.3 Recent developments
- 19.1.5.3.1 Product approvals
- 19.1.5.4 MnM view
- 19.1.5.4.1 Key strengths
- 19.1.5.4.2 Strategic choices
- 19.1.5.4.3 Weaknesses & competitive threats
- 19.1.6 BECTON, DICKINSON AND COMPANY (BD)
- 19.1.6.1 Business overview
- 19.1.6.2 Products offered
- 19.1.6.3 Recent developments
- 19.1.6.3.1 Deals
- 19.1.6.3.2 Expansions
- 19.1.7 KONINKLIJKE PHILIPS N.V.
- 19.1.7.1 Business overview
- 19.1.7.2 Products offered
- 19.1.7.3 Recent developments
- 19.1.7.3.1 Deals
- 19.1.7.3.2 Expansions
- 19.1.8 MERCK KGAA
- 19.1.8.1 Business overview
- 19.1.8.2 Products offered
- 19.1.8.3 Recent developments
- 19.1.8.3.1 Expansions
- 19.1.9 SECTRA AB
- 19.1.9.1 Business overview
- 19.1.9.2 Products offered
- 19.1.9.3 Recent developments
- 19.1.9.3.1 Product approvals
- 19.1.9.3.2 Deals
- 19.1.9.3.3 Expansions
- 19.1.10 SAKURA FINETEK JAPAN CO., LTD.
- 19.1.10.1 Business overview
- 19.1.10.2 Products offered
- 19.1.10.3 Recent developments
- 19.1.10.3.1 Product launches
- 19.1.10.3.2 Deals
- 19.1.10.3.3 Expansions
- 19.1.1 F. HOFFMANN-LA ROCHE LTD.
- 19.2 OTHER PLAYERS
- 19.2.1 BIO SB
- 19.2.2 BIOGENEX
- 19.2.3 MILESTONE MEDICAL
- 19.2.4 HISTO-LINE LABORATORIES
- 19.2.5 DIAPATH S.P.A.
- 19.2.6 SLEE MEDICAL GMBH
- 19.2.7 AMOS SCIENTIFIC PTY LTD.
- 19.2.8 MEDITE MEDICAL GMBH
- 19.2.9 CELL SIGNALING TECHNOLOGY, INC.
- 19.2.10 CELLPATH LTD.
- 19.2.11 MICROS AUSTRIA
- 19.2.12 R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED
- 19.2.13 RWD LIFE SCIENCE CO., LTD.
- 19.2.14 MEDIMEAS
- 19.2.15 BRIGHT INSTRUMENTS
- 19.2.16 JINHUA YIDI MEDICAL APPLIANCE CO., LTD.
- 19.2.17 HAMAMATSU PHOTONICS K.K.
- 19.2.18 3DHISTECH LTD.
- 19.2.19 OPTRASCAN
- 19.2.20 DAKEWE
20 RESEARCH METHODOLOGY
- 20.1 RESEARCH DATA
- 20.1.1 SECONDARY DATA
- 20.1.1.1 List of secondary sources
- 20.1.1.2 Key data from secondary sources
- 20.1.2 PRIMARY DATA
- 20.1.2.1 Breakdown of primary interviews
- 20.1.1 SECONDARY DATA
- 20.2 MARKET SIZE ESTIMATION
- 20.2.1 TOTAL MARKET SIZE: ANATOMIC PATHOLOGY MARKET
- 20.2.2 BOTTOM-UP APPROACH
- 20.2.2.1 Approach 2: Study of annual reports and investor presentations
- 20.2.2.2 Approach 3: Primary interviews
- 20.2.2.3 Growth forecast
- 20.2.3 TOP-DOWN APPROACH
- 20.3 DATA TRIANGULATION
- 20.4 RESEARCH ASSUMPTIONS
- 20.4.1 STUDY-RELATED ASSUMPTIONS
- 20.5 STUDY ASSUMPTIONS
- 20.5.1 PARAMETRIC ASSUMPTIONS
- 20.5.2 GROWTH RATE ASSUMPTIONS
- 20.6 RESEARCH LIMITATIONS
- 20.7 RISK ASSESSMENT
21 APPENDIX
- 21.1 DISCUSSION GUIDE
- 21.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 21.3 CUSTOMIZATION OPTIONS
- 21.4 RELATED REPORTS
- 21.5 AUTHOR DETAILS
Product Code: MD 5104
List of Tables
- TABLE 1 INCREASING INCIDENCE OF CANCER, BY REGION, 2024 VS. 2030 VS. 2040 (MILLION)
- TABLE 2 PROJECTED INCREASE IN GLOBAL NUMBER OF CANCER PATIENTS, 2024 VS. 2030 VS. 2040 (MILLION)
- TABLE 3 % OF PERSONALIZED MEDICINES IN OVERALL DRUG APPROVAL BY FDA, 2015-2024
- TABLE 4 ANATOMIC PATHOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
- TABLE 5 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023-2030
- TABLE 6 NORTH AMERICA: MACROECONOMIC INDICATORS
- TABLE 7 EUROPE: MACROECONOMIC INDICATORS
- TABLE 8 ASIA PACIFIC: MACROECONOMIC INDICATORS
- TABLE 9 LATIN AMERICA: MACROECONOMIC INDICATORS
- TABLE 10 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
- TABLE 11 AVERAGE SELLING PRICE OF ANATOMIC PATHOLOGY PRODUCTS, BY KEY PLAYER, 2024-2026 (USD)
- TABLE 12 AVERAGE SELLING PRICE OF ANATOMIC PATHOLOGY PRODUCTS, BY REGION, 2024-2026 (USD)
- TABLE 13 IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
- TABLE 14 EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
- TABLE 15 ANATOMIC PATHOLOGY MARKET: KEY CONFERENCES & EVENTS, 2026-2027
- TABLE 16 US-ADJUSTED RECIPROCAL TARIFF RATES
- TABLE 17 KEY PATENTS IN ANATOMIC PATHOLOGY MARKET, 2022-2026
- TABLE 18 KEY COMPANIES IMPLEMENTING AI IN ANATOMIC PATHOLOGY MARKET
- TABLE 19 CLASSIFICATION OF IVD DEVICES IN EUROPE
- TABLE 20 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN
- TABLE 21 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 22 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 23 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 24 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 25 REST OF THE WORLD: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)
- TABLE 27 KEY BUYING CRITERIA, BY END USER
- TABLE 28 ADOPTION BARRIERS & INTERNAL CHALLENGES
- TABLE 29 ANATOMIC PATHOLOGY MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
- TABLE 30 ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 31 ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 32 ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 33 ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 34 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 35 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 36 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 37 ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 38 ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 39 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 40 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 41 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 42 PRIMARY HISTOPATHOLOGY ANTIBODIES AVAILABLE IN MARKET
- TABLE 43 ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY HISTOPATHOLOGY ANTIBODIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 44 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 45 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 46 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 47 ANATOMIC PATHOLOGY PRODUCT MARKET FOR SECONDARY HISTOPATHOLOGY ANTIBODIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 48 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SECONDARY HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 49 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SECONDARY HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 50 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SECONDARY HISTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 51 ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 52 ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 53 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 54 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 55 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 56 ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY STAINS & SOLVENTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 57 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY STAINS & SOLVENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 58 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY STAINS & SOLVENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 59 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY STAINS & SOLVENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 60 ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY FIXATIVES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 61 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY FIXATIVES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 62 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY FIXATIVES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 63 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY FIXATIVES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 64 ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER HISTOPATHOLOGY KITS & REAGENTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 65 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER HISTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 66 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER HISTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 67 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER HISTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 68 HISTOPATHOLOGY PROBES AVAILABLE IN MARKET
- TABLE 69 ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY PROBES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 70 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY PROBES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 71 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY PROBES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 72 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY PROBES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 73 ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER HISTOPATHOLOGY CONSUMABLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 74 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER HISTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 75 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER HISTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 76 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER HISTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 77 ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 78 ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 79 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 80 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 81 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 82 ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 83 ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 84 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 85 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 86 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 87 PRIMARY CYTOPATHOLOGY ANTIBODIES AVAILABLE IN MARKET
- TABLE 88 ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY CYTOPATHOLOGY ANTIBODIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 89 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 90 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 91 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 92 ANATOMIC PATHOLOGY PRODUCT MARKET FOR SECONDARY CYTOPATHOLOGY ANTIBODIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 93 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SECONDARY CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 94 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SECONDARY CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 95 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SECONDARY CYTOPATHOLOGY ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 96 ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 97 ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 98 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 99 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 100 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 101 ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY STAINS & SOLVENTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 102 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY STAINS & SOLVENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 103 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY STAINS & SOLVENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 104 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY STAINS & SOLVENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 105 ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY FIXATIVES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 106 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY FIXATIVES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 107 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY FIXATIVES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 108 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY FIXATIVES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 109 ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER CYTOPATHOLOGY KITS & REAGENTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 110 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER CYTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 111 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER CYTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 112 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER CYTOPATHOLOGY KITS & REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 113 ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY PROBES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 114 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY PROBES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 115 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY PROBES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 116 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY PROBES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 117 ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER CYTOPATHOLOGY CONSUMABLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 118 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER CYTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 119 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER CYTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 120 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER CYTOPATHOLOGY CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 121 ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 122 KEY SLIDE STAINING SYSTEMS AVAILABLE IN MARKET
- TABLE 123 ANATOMIC PATHOLOGY PRODUCT MARKET FOR SLIDE STAINING SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 124 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SLIDE STAINING SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 125 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SLIDE STAINING SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 126 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SLIDE STAINING SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 127 KEY TISSUE PROCESSING SYSTEMS AVAILABLE IN MARKET
- TABLE 128 ANATOMIC PATHOLOGY PRODUCT MARKET FOR TISSUE PROCESSING SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 129 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 130 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 131 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 132 ANATOMIC PATHOLOGY PRODUCT MARKET FOR CELL PROCESSORS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 133 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CELL PROCESSORS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 134 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CELL PROCESSORS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 135 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CELL PROCESSORS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 136 MICROTOMES AVAILABLE IN MARKET
- TABLE 137 ANATOMIC PATHOLOGY PRODUCT MARKET FOR MICROTOMES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 138 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR MICROTOMES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 139 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR MICROTOMES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 140 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR MICROTOMES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 141 ANATOMIC PATHOLOGY PRODUCT MARKET FOR EMBEDDING SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 142 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR EMBEDDING SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 143 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR EMBEDDING SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 144 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR EMBEDDING SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 145 ANATOMIC PATHOLOGY PRODUCT MARKET FOR COVERSLIPPERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 146 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR COVERSLIPPERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 147 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR COVERSLIPPERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 148 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR COVERSLIPPERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 149 DIGITAL PATHOLOGY SCANNERS AVAILABLE IN MARKET
- TABLE 150 ANATOMIC PATHOLOGY PRODUCT MARKET FOR DIGITAL PATHOLOGY SCANNERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 151 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR DIGITAL PATHOLOGY SCANNERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 152 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR DIGITAL PATHOLOGY SCANNERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 153 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR DIGITAL PATHOLOGY SCANNERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 154 ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER INSTRUMENTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 155 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 156 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 157 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 158 SOFTWARE AVAILABLE IN MARKET
- TABLE 159 ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 160 ANATOMIC PATHOLOGY PRODUCT MARKET FOR AI-INTEGRATED SOFTWARE, BY REGION, 2024-2031 (USD MILLION)
- TABLE 161 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR AI-INTEGRATED SOFTWARE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 162 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR AI-INTEGRATED SOFTWARE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 163 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR AI-INTEGRATED SOFTWARE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 164 ANATOMIC PATHOLOGY PRODUCT MARKET FOR NON-AI-INTEGRATED SOFTWARE, BY REGION, 2024-2031 (USD MILLION)
- TABLE 165 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR NON-AI-INTEGRATED SOFTWARE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 166 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR NON-AI-INTEGRATED SOFTWARE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 167 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR NON-AI-INTEGRATED SOFTWARE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 168 ANATOMIC PATHOLOGY PRODUCT MARKET FOR STORAGE SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 169 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR STORAGE SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 170 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR STORAGE SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 171 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR STORAGE SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 172 ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 173 ANATOMIC PATHOLOGY PRODUCT MARKET FOR PREANALYTICS/SAMPLE PREPARATION, BY REGION, 2024-2031 (USD MILLION)
- TABLE 174 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PREANALYTICS/SAMPLE PREPARATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 175 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PREANALYTICS/SAMPLE PREPARATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 176 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PREANALYTICS/SAMPLE PREPARATION, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 177 ANATOMIC PATHOLOGY PRODUCT MARKET FOR ADVANCED STAINING/IHC, BY REGION, 2024-2031 (USD MILLION)
- TABLE 178 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR ADVANCED STAINING/IHC, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 179 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR ADVANCED STAINING/IHC, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 180 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR ADVANCED STAINING/IHC, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 181 ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY & SPECIAL STAINING, BY REGION, 2024-2031 (USD MILLION)
- TABLE 182 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY & SPECIAL STAINING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 183 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY & SPECIAL STAINING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 184 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PRIMARY & SPECIAL STAINING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 185 ANATOMIC PATHOLOGY PRODUCT MARKET FOR DIGITAL PATHOLOGY, BY REGION, 2024-2031 (USD MILLION)
- TABLE 186 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR DIGITAL PATHOLOGY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 187 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR DIGITAL PATHOLOGY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 188 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR DIGITAL PATHOLOGY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 189 GLOBAL CANCER INCIDENCE, 2022 VS. 2040
- TABLE 190 ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 191 BREAST CANCER INCIDENCE, BY REGION, 2024 VS. 2050
- TABLE 192 ANATOMIC PATHOLOGY PRODUCT MARKET FOR BREAST CANCER, BY REGION, 2024-2031 (USD MILLION)
- TABLE 193 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR BREAST CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 194 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR BREAST CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 195 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR BREAST CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 196 ANATOMIC PATHOLOGY PRODUCT MARKET FOR NON-SMALL-CELL LUNG CANCER, BY REGION, 2024-2031 (USD MILLION)
- TABLE 197 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR NON-SMALL-CELL LUNG CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 198 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR NON-SMALL-CELL LUNG CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 199 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR NON-SMALL-CELL LUNG CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 200 PROSTATE CANCER INCIDENCE, BY REGION, 2024 VS. 2050
- TABLE 201 ANATOMIC PATHOLOGY PRODUCT MARKET FOR PROSTATE CANCER, BY REGION, 2024-2031 (USD MILLION)
- TABLE 202 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PROSTATE CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 203 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PROSTATE CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 204 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PROSTATE CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 205 ANATOMIC PATHOLOGY PRODUCT MARKET FOR GASTRIC CANCER, BY, BY REGION, 2024-2031 (USD MILLION)
- TABLE 206 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR GASTRIC CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 207 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR GASTRIC CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 208 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR GASTRIC CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 209 HODGKIN LYMPHOMA INCIDENCE, BY REGION, 2024 VS. 2050
- TABLE 210 NON-HODGKIN LYMPHOMA INCIDENCE, BY REGION, 2024 VS. 2050
- TABLE 211 ANATOMIC PATHOLOGY PRODUCT MARKET FOR LYMPHOMA, BY REGION, 2024-2031 (USD MILLION)
- TABLE 212 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR LYMPHOMA, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 213 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR LYMPHOMA, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 214 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR LYMPHOMA, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 215 ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER DISEASES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 216 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER DISEASES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 217 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER DISEASES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 218 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER DISEASES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 219 ANATOMIC PATHOLOGY MARKET, BY DISEASE, 2024-2031 (NO. OF TESTS)
- TABLE 220 ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 221 ANATOMIC PATHOLOGY PRODUCT MARKET FOR HOSPITALS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 222 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HOSPITALS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 223 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HOSPITALS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 224 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HOSPITALS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 225 ANATOMIC PATHOLOGY PRODUCT MARKET FOR RESEARCH LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 226 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 227 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 228 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 229 ANATOMIC PATHOLOGY PRODUCT MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 230 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 231 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 232 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 233 ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 234 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 235 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 236 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 237 ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 238 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 239 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 240 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 241 ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 242 ANATOMIC PATHOLOGY SERVICE MARKET FOR HISTOPATHOLOGY SERVICES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 243 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR HISTOPATHOLOGY SERVICES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 244 EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR HISTOPATHOLOGY SERVICES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 245 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICES MARKET FOR HISTOPATHOLOGY SERVICES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 246 ANATOMIC PATHOLOGY SERVICE MARKET FOR CYTOPATHOLOGY SERVICES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 247 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR CYTOPATHOLOGY SERVICES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 248 EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR CYTOPATHOLOGY SERVICES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 249 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR CYTOPATHOLOGY SERVICES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 250 ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 251 ANATOMIC PATHOLOGY SERVICE MARKET FOR IN-HOUSE, BY REGION, 2024-2031 (USD MILLION)
- TABLE 252 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR IN-HOUSE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 253 EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR IN-HOUSE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 254 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR IN-HOUSE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 255 ANATOMIC PATHOLOGY SERVICE MARKET FOR OUTSOURCED, BY REGION, 2024-2031 (USD MILLION)
- TABLE 256 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR OUTSOURCED, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 257 EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR OUTSOURCED, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 258 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR OUTSOURCED, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 259 ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 260 ANATOMIC PATHOLOGY SERVICE MARKET FOR BREAST CANCER, BY REGION, 2024-2031 (USD MILLION)
- TABLE 261 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR BREAST CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 262 EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR BREAST CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 263 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR BREAST CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 264 ANATOMIC PATHOLOGY SERVICE MARKET FOR NON-SMALL CELL LUNG CANCER, BY REGION, 2024-2031 (USD MILLION)
- TABLE 265 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR NON-SMALL CELL LUNG CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 266 EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR NON-SMALL CELL LUNG CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 267 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR NON-SMALL CELL LUNG CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 268 ANATOMIC PATHOLOGY SERVICE MARKET FOR PROSTATE CANCER, BY REGION, 2024-2031 (USD MILLION)
- TABLE 269 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR PROSTATE CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 270 EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR PROSTATE CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 271 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR PROSTATE CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 272 ANATOMIC PATHOLOGY SERVICE MARKET FOR GASTRIC CANCER, BY, BY REGION, 2024-2031 (USD MILLION)
- TABLE 273 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR GASTRIC CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 274 EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR GASTRIC CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 275 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR GASTRIC CANCER, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 276 ANATOMIC PATHOLOGY SERVICE MARKET FOR LYMPHOMA, BY, BY REGION, 2024-2031 (USD MILLION)
- TABLE 277 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR LYMPHOMA, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 278 EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR LYMPHOMA, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 279 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR LYMPHOMA, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 280 ANATOMIC PATHOLOGY SERVICE MARKET FOR OTHER DISEASE TYPE, BY REGION, 2024-2031 (USD MILLION)
- TABLE 281 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET FOR OTHER DISEASE TYPE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 282 EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET FOR OTHER DISEASE TYPE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 283 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET FOR OTHER DISEASE TYPE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 284 ANATOMIC PATHOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 285 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 286 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 287 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 288 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 289 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 290 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 291 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 292 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 293 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 294 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 295 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 296 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 297 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 298 NORTH AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 299 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 300 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 301 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 302 US CANCER INCIDENCE, BY CANCER TYPE, 2024 VS. 2050
- TABLE 303 US: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 304 US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 305 US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 306 US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 307 US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 308 US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 309 US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 310 US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 311 US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 312 US: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 313 US: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 314 US: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 315 US: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 316 US: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 317 US: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 318 US: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 319 CANADA CANCER INCIDENCE, BY CANCER TYPE, 2024 VS. 2050
- TABLE 320 CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 321 CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 322 CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 323 CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 324 CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 325 CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 326 CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 327 CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 328 CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 329 CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 330 CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 331 CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 332 CANADA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 333 CANADA: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 334 CANADA: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 335 CANADA: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 336 EUROPE: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 337 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 338 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 339 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 340 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 341 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 342 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 343 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 344 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 345 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 346 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 347 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 348 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 349 EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 350 EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 351 EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 352 EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 353 GERMANY: CANCER INCIDENCE, BY TYPE, 2024 VS. 2050
- TABLE 354 GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 355 GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 356 GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 357 GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 358 GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 359 GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 360 GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 361 GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 362 GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 363 GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 364 GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 365 GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 366 GERMANY: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 367 GERMANY: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 368 GERMANY: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 369 GERMANY: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 370 UK: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 371 UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 372 UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 373 UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 374 UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 375 UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 376 UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 377 UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 378 UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 379 UK: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 380 UK: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 381 UK: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 382 UK: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 383 UK: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 384 UK: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 385 UK: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 386 FRANCE: CANCER INCIDENCE, BY TYPE, 2024 VS. 2050
- TABLE 387 FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 388 FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 389 FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 390 FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 391 FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 392 FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 393 FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 394 FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 395 FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 396 FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 397 FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 398 FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 399 FRANCE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 400 FRANCE: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 401 FRANCE: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 402 FRANCE: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 403 ITALY: CANCER INCIDENCE, BY TYPE, 2024 VS. 2050
- TABLE 404 ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 405 ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 406 ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 407 ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 408 ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 409 ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 410 ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 411 ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 412 ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 413 ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 414 ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 415 ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 416 ITALY: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 417 ITALY: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 418 ITALY: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 419 ITALY: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 420 SPAIN: CANCER INCIDENCE, BY TYPE, 2024 VS. 2050
- TABLE 421 SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 422 SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 423 SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 424 SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 425 SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 426 SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 427 SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 428 SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 429 SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 430 SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 431 SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 432 SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 433 SPAIN: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 434 SPAIN: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 435 SPAIN: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 436 SPAIN: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 437 REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 438 REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 439 REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 440 REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 441 REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 442 REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 443 REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 444 REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 445 REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 446 REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 447 REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 448 REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 449 REST OF EUROPE: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 450 REST OF EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 451 REST OF EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 452 REST OF EUROPE: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 453 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 454 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 455 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 456 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 457 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 458 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 459 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 460 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 461 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 462 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 463 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 464 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 465 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 466 ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 467 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 468 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 469 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 470 CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 471 CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 472 CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 473 CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 474 CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 475 CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 476 CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 477 CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 478 CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 479 CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 480 CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 481 CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 482 CHINA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 483 CHINA: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 484 CHINA: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 485 CHINA: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 486 CANCER INCIDENCE, BY CANCER TYPE (JAPAN), 2024 VS. 2050
- TABLE 487 JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 488 JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 489 JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 490 JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 491 JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 492 JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 493 JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 494 JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 495 JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 496 JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 497 JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 498 JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 499 JAPAN: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 500 JAPAN: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 501 JAPAN: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 502 JAPAN: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 503 INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 504 INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 505 INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 506 INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 507 INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 508 INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 509 INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 510 INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 511 INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 512 INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 513 INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 514 INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 515 INDIA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 516 INDIA: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 517 INDIA: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 518 INDIA: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 519 REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 520 REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 521 REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 522 REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 523 REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 524 REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 525 REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 526 REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 527 REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 528 REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 529 REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 530 REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 531 REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 532 REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 533 REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 534 REST OF ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 535 LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 536 LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 537 LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 538 LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 539 LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 540 LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 541 LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 542 LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 543 LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 544 LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 545 LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 546 LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 547 LATIN AMERICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 548 LATIN AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 549 LATIN AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 550 LATIN AMERICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 551 MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 552 MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 553 MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 554 MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 555 MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR HISTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 556 MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 557 MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY ANTIBODIES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 558 MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR CYTOPATHOLOGY KITS & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 559 MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 560 MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 561 MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY PROCESS, 2024-2031 (USD MILLION)
- TABLE 562 MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 563 MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY PRODUCT MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 564 MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 565 MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY MODEL, 2024-2031 (USD MILLION)
- TABLE 566 MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY SERVICE MARKET, BY DISEASE, 2024-2031 (USD MILLION)
- TABLE 567 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN ANATOMIC PATHOLOGY MARKET, JANUARY 2023-JULY 2026
- TABLE 568 ANATOMIC PATHOLOGY MARKET: DEGREE OF COMPETITION
- TABLE 569 ANATOMIC PATHOLOGY MARKET: REGION FOOTPRINT
- TABLE 570 ANATOMIC PATHOLOGY MARKET: TYPE FOOTPRINT
- TABLE 571 ANATOMIC PATHOLOGY MARKET: PROCESS FOOTPRINT
- TABLE 572 ANATOMIC PATHOLOGY MARKET: END-USER FOOTPRINT
- TABLE 573 ANATOMICAL PATHOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SMES
- TABLE 574 ANATOMIC PATHOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2)
- TABLE 575 ANATOMIC PATHOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/ SMES (2/2)
- TABLE 576 ANATOMIC PATHOLOGY MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023- JULY 2026
- TABLE 577 ANATOMIC PATHOLOGY MARKET: DEALS, JANUARY 2023-JULY 2026
- TABLE 578 ANATOMIC PATHOLOGY MARKET: EXPANSIONS, JANUARY 2023- JULY 2026
- TABLE 579 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
- TABLE 580 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
- TABLE 581 F. HOFFMAN-LA ROCHE LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
- TABLE 582 F. HOFFMAN-LA ROCHE LTD.: DEALS, JANUARY 2023-JULY 2026
- TABLE 583 DANAHER CORPORATION: COMPANY OVERVIEW
- TABLE 584 DANAHER: PRODUCTS OFFERED
- TABLE 585 DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
- TABLE 586 DANAHER CORPORATION: DEALS, JANUARY 2023-JULY 2026
- TABLE 587 PHC HOLDINGS CORPORATION: COMPANY OVERVIEW
- TABLE 588 PHC HOLDINGS CORPORATION: PRODUCTS OFFERED
- TABLE 589 PHC HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-OCTOBER 2025
- TABLE 590 PHC HOLDINGS CORPORATION: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 591 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
- TABLE 592 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
- TABLE 593 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
- TABLE 594 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023-JULY 2026
- TABLE 595 HOLOGIC INC.: COMPANY OVERVIEW
- TABLE 596 HOLOGIC INC.: PRODUCTS OFFERED
- TABLE 597 HOLOGIC, INC.: PRODUCT APPROVALS, JANUARY 2023-JULY 2026
- TABLE 598 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
- TABLE 599 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED
- TABLE 600 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2023-JULY 2026
- TABLE 601 BECTON, DICKINSON AND COMPANY: EXPANSIONS, JANUARY 2023-JULY 2026
- TABLE 602 KONINKLIJKE PHILIPS N.V: COMPANY OVERVIEW
- TABLE 603 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
- TABLE 604 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023-JULY 2026
- TABLE 605 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2023-JULY 2026
- TABLE 606 MERCK KGAA: COMPANY OVERVIEW
- TABLE 607 MERCK KGAA: PRODUCTS OFFERED
- TABLE 608 MERCK KGAA: EXPANSIONS, JANUARY 2023-JULY 2026
- TABLE 609 SECTRA AB: COMPANY OVERVIEW
- TABLE 610 SECTRA AB: PRODUCTS OFFERED
- TABLE 611 SECTRA AB: PRODUCT APPROVALS, JANUARY 2023-JULY 2026
- TABLE 612 SECTRA AB: DEALS, JANUARY 2023-JULY 2026
- TABLE 613 SECTRA AB: EXPANSIONS, JANUARY 2023-JULY 2026
- TABLE 614 SAKURA FINETEK JAPAN CO., LTD.: COMPANY OVERVIEW
- TABLE 615 SAKURA FINETEK JAPAN CO., LTD.: PRODUCTS OFFERED
- TABLE 616 SAKURA FINETEK JAPAN CO., LTD.: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
- TABLE 617 SAKURA FINETEK JAPAN CO., LTD.: DEALS, JANUARY 2023-JULY 2026
- TABLE 618 SAKURA FINETEK JAPAN CO., LTD.: EXPANSIONS, JANUARY 2023-JULY 2026
- TABLE 619 BIO SB: COMPANY OVERVIEW
- TABLE 620 BIOGENEX: COMPANY OVERVIEW
- TABLE 621 MILESTONE MEDICAL: COMPANY OVERVIEW
- TABLE 622 HISTO-LINE LABORATORIES: COMPANY OVERVIEW
- TABLE 623 DIAPATH S.P.A.: COMPANY OVERVIEW
- TABLE 624 SLEE MEDICAL GMBH: COMPANY OVERVIEW
- TABLE 625 AMOS SCIENTIFIC PTY LTD.: COMPANY OVERVIEW
- TABLE 626 MEDITE MEDICAL GMBH: COMPANY OVERVIEW
- TABLE 627 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW
- TABLE 628 CELLPATH LTD.: COMPANY OVERVIEW
- TABLE 629 MICROS AUSTRIA: COMPANY OVERVIEW
- TABLE 630 R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED: COMPANY OVERVIEW
- TABLE 631 RWD LIFE SCIENCE CO., LTD.: COMPANY OVERVIEW
- TABLE 632 MEDIMEAS: COMPANY OVERVIEW
- TABLE 633 BRIGHT INSTRUMENTS: COMPANY OVERVIEW
- TABLE 634 JINHUA YIDI MEDICAL APPLIANCE CO., LTD.: COMPANY OVERVIEW
- TABLE 635 HAMAMATSU PHOTONICS K.K.: COMPANY OVERVIEW
- TABLE 636 3DHISTECH LTD.: COMPANY OVERVIEW
- TABLE 637 OPTRASCAN: COMPANY OVERVIEW
- TABLE 638 DAKEWE: COMPANY OVERVIEW
- TABLE 639 KEY DATA FROM PRIMARY SOURCES
- TABLE 640 ANATOMIC PATHOLOGY MARKET: RISK ASSESSMENT
List of Figures
- FIGURE 1 ANATOMIC PATHOLOGY MARKET SEGMENTATION & REGIONAL SCOPE
- FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS
- FIGURE 3 GLOBAL ANATOMIC PATHOLOGY MARKET, 2024-2031
- FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ANATOMIC PATHOLOGY MARKET, 2023-2025
- FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF ANATOMIC PATHOLOGY MARKET
- FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN ANATOMIC PATHOLOGY MARKET, 2025
- FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
- FIGURE 8 RISING CASES OF CANCER TO DRIVE MARKET GROWTH DURING FORECAST PERIOD
- FIGURE 9 CONSUMABLES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
- FIGURE 10 PREANALYTICS/SAMPLE PREPARATION SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
- FIGURE 11 BREAST CANCER SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
- FIGURE 12 HOSPITALS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
- FIGURE 13 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
- FIGURE 14 ANATOMIC PATHOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 15 ANATOMIC PATHOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 16 ANATOMIC PATHOLOGY MARKET: SUPPLY CHAIN ANALYSIS
- FIGURE 17 ANATOMIC PATHOLOGY MARKET: VALUE CHAIN ANALYSIS
- FIGURE 18 ANATOMIC PATHOLOGY MARKET: ECOSYSTEM ANALYSIS
- FIGURE 19 ANATOMIC PATHOLOGY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- FIGURE 20 NUMBER OF DEALS & FUNDING ACTIVITIES IN ANATOMIC PATHOLOGY MARKET
- FIGURE 21 PATENT ANALYSIS FOR ANATOMIC PATHOLOGY, JANUARY 2016-DECEMBER 2025
- FIGURE 22 MARKET POTENTIAL OF AI IN ANATOMIC PATHOLOGY MARKET
- FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
- FIGURE 24 KEY BUYING CRITERIA, BY END USER
- FIGURE 25 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET SNAPSHOT
- FIGURE 26 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET SNAPSHOT
- FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN ANATOMIC PATHOLOGY MARKET, 2023-2025 (USD MILLION)
- FIGURE 28 ANATOMIC PATHOLOGY MARKET SHARE ANALYSIS, 2025 (GLOBAL)
- FIGURE 29 ANATOMIC PATHOLOGY MARKET SHARE ANALYSIS, 2025 (US)
- FIGURE 30 ANATOMIC PATHOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
- FIGURE 31 ANATOMIC PATHOLOGY MARKET: COMPANY FOOTPRINT
- FIGURE 32 ANATOMIC PATHOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
- FIGURE 33 EV/EBITDA OF KEY VENDORS
- FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 35 ANATOMIC PATHOLOGY MARKET: BRAND/PRODUCT COMPARISON FOR ANATOMIC PATHOLOGY
- FIGURE 36 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
- FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 38 PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 39 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 40 HOLOGIC INC.: COMPANY SNAPSHOT (2025)
- FIGURE 41 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT (2025)
- FIGURE 42 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
- FIGURE 43 MERCK KGAA: COMPANY SNAPSHOT (2025)
- FIGURE 44 SECTRA AB: COMPANY SNAPSHOT (2025)
- FIGURE 45 RESEARCH DESIGN
- FIGURE 46 LIST OF PRIMARY SOURCES
- FIGURE 47 KEY INDUSTRY INSIGHTS
- FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
- FIGURE 49 APPROACH 1: REVENUE ESTIMATION OF KEY PLAYERS
- FIGURE 50 CAGR PROJECTIONS
- FIGURE 51 TOP-DOWN APPROACH
- FIGURE 52 DATA TRIANGULATION
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.